ICSI and conventional IVF, which one should be prefered for cases of pre-implantation genetic testing?

Ever since its implementation in 1992, the intra-cytoplasmic sperm injection (ICSI) technique has been hailed as a game-changer for enhancing the outcomes of in vitro fertilization (IVF) treatment in cases of infertility due to male factors. However, ICSI was later widely applied to cases of infertility not due to male factors without evidence proving its effectiveness. According to the 2022 report of the European IVF Monitoring Council (EIM), the rate of fertilization cases using ICSI method accounts for 70% of IVF cases in European countries, meanwhile the conventional IVF method accounts for only 30% and this rate has remained stable from 2006 until recently. The question is whether cases of infertility not due to male factors that are indicated for pre-implantation genetic testing (PGT) should be fertilized and create embryos using ICSI or conventional IVF to minimize invasiveness and reduce costs while still ensuring the accuracy of the test results.